Skip to main content
Top
Published in: Rheumatology International 2/2019

01-02-2019 | Cases with a Message

Thrombotic microangiopathy in a patient with eosinophilic granulomatosis with polyangiitis: case-based review

Authors: Jon Badiola, Nuria Navarrete-Navarrete, José Mario Sabio

Published in: Rheumatology International | Issue 2/2019

Login to get access

Abstract

The correct diagnosis, classification and therapeutic management of thrombotic microangiopathies (TMA) continue to be a challenge for the clinician. We report a rare case of eosinophilic granulomatosis with polyangiitis (EGPA) as a trigger for complement-mediated TMA in a 57-year-old man who was successfully treated with corticoids, cyclophosphamide and therapeutic plasma exchange. Additionally, we review few other cases reported in the literature and the pathophysiological pathway of association between TMA and EGPA. We found that the mutual relationships between the inflammation triggered by vasculitis, the exacerbated complement activation, together with hypereosinophilia and endothelial damage seem to be the key in explaining the connection between both entities. We suggest that an understanding of the multi-causal nature of TMAs is crucial for the correct diagnosis and treatment of these patients.
Literature
1.
6.
go back to reference Masi AT, Hunder GG, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100CrossRefPubMed Masi AT, Hunder GG, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100CrossRefPubMed
8.
12.
go back to reference Fujimura Y, Matsumoto M (2010) Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998–2008. Intern Med 49:7–15CrossRefPubMed Fujimura Y, Matsumoto M (2010) Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998–2008. Intern Med 49:7–15CrossRefPubMed
17.
go back to reference Maino A, Rossio R, Cugno M et al (2012) Hypereosinophilic syndrome, Churg–Strauss syndrome and parasitic diseases: possible links between eosinophilia and thrombosis. Curr Vasc Pharmacol 10:670–675CrossRefPubMed Maino A, Rossio R, Cugno M et al (2012) Hypereosinophilic syndrome, Churg–Strauss syndrome and parasitic diseases: possible links between eosinophilia and thrombosis. Curr Vasc Pharmacol 10:670–675CrossRefPubMed
22.
go back to reference Ohguchi H, Sugawara T, Harigae H (2009) Thrombotic thrombocytopenic purpura complicated with hypereosinophilic syndrome. Intern Med 48:1687–1690CrossRefPubMed Ohguchi H, Sugawara T, Harigae H (2009) Thrombotic thrombocytopenic purpura complicated with hypereosinophilic syndrome. Intern Med 48:1687–1690CrossRefPubMed
Metadata
Title
Thrombotic microangiopathy in a patient with eosinophilic granulomatosis with polyangiitis: case-based review
Authors
Jon Badiola
Nuria Navarrete-Navarrete
José Mario Sabio
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 2/2019
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-018-4228-5

Other articles of this Issue 2/2019

Rheumatology International 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.